Thrombin promotes arteriogenesis and hemodynamic recovery in a rabbit hindlimb ischemia model  Konstantinos Katsanos, MD, Dimitrios Karnabatidis, MD,

Slides:



Advertisements
Similar presentations
Assessment of mouse hind limb endothelial function by measuring femoral artery blood flow responses  Chao-Hung Wang, MD, Kuo-Ti Chen, MS, Hsiu-Fu Mei,
Advertisements

Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower.
Large renal artery aneurysm in Takayasu arteritis
Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia  Go Kuwahara,
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial.
A case of intravascular epithelioid hemangioendothelioma occurring 14 years after coil embolization for an extracranial internal carotid artery aneurysm 
Castration of male mice prevents the progression of established angiotensin II-induced abdominal aortic aneurysms  Xuan Zhang, PhD, Sean Thatcher, PhD,
Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model  Abdulaziz Al-Khaldi, MD, Hilal.
In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia  Geoffrey O. Ouma,
Ulka Sachdev, MD, Xiangdong Cui, MS, Edith Tzeng, MD 
Elevation of hemopexin-like fragment of matrix metalloproteinase-2 tissue levels inhibits ischemic wound healing and angiogenesis  April E. Nedeau, MD,
The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia  Stephen M. Bauer, MD, Lee J. Goldstein,
Hypertensive extracorporeal limb perfusion (HELP): A new technique for managing critical lower limb ischemia  Rodney J. Lane, MD, Mark Phillips, PhD,
Immunoglobulin G4-related multiple cardiovascular lesions successfully treated with a combination of open surgery and corticosteroid therapy  Meikun Kan-o,
Gale Tang, MD, David N. Charo, Rong Wang, PhD, Israel F
Bilateral ischemic lumbosacral plexopathy from chronic aortoiliac occlusion presenting with progressive paraplegia  Hyangkyoung Kim, MD, PhD, Si Hyun.
Angiogenic properties of human placenta-derived adherent cells and efficacy in hindlimb ischemia  Aleksandar Francki, PhD, Kristen Labazzo, PhD, Shuyang.
Lipoplex gene transfer of inducible nitric oxide synthase inhibits the reactive intimal hyperplasia after expanded polytetrafluoroethylene bypass grafting 
Robert A. Brenes, MD, Caroline C
Polydeoxyribonucleotide restores blood flow in an experimental model of ischemic skin flaps  Francesca Polito, PhD, Alessandra Bitto, MD, PhD, Mariarosaria.
Combination of stromal-derived factor-1α and vascular endothelial growth factor gene- modified endothelial progenitor cells is more effective for ischemic.
Regulation of new blood vessel growth into ischemic skeletal muscle
Ryan M. McEnaney, MD, Ankur Shukla, MD, Michael C
Ulka Sachdev, MD, Xiangdong Cui, MS, Edith Tzeng, MD 
Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical.
The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia  Gale L. Tang,
Intramyocardial thrombin promotes angiogenesis and improves cardiac function in an experimental rabbit model of acute myocardial infarction  Sofoklis.
Cellular and molecular mechanism regulating blood flow recovery in acute versus gradual femoral artery occlusion are distinct in the mouse  Yagai Yang,
Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model  Noriko Takahashi, MD, Rei.
Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit.
Galit Ankri-Eliahoo, PhD, Kevin Weitz, BS, Timothy C. Cox, PhD, Gale L
Polydeoxyribonucleotide (PDRN) restores blood flow in an experimental model of peripheral artery occlusive disease  Alessandra Bitto, MD, Francesca Polito,
Direct sonographic-guided superior gluteal artery access for treatment of a previously treated expanding internal iliac artery aneurysm  Michael M. Herskowitz,
Endovascular aneurysmal models at the external iliac artery of dogs
Endothelial nitric oxide synthase affects both early and late collateral arterial adaptation and blood flow recovery after induction of hind limb ischemia.
Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation  Akira Marui, MD, Akihiro.
Therapeutic site selection is important for the successful development of collateral vessels  Ayako Nishiyama, MD, PhD, Hiroyuki Koyama, MD, PhD, Tetsuro.
International Journal of Cardiology
Endovascular native vessel recanalization to maintain limb perfusion after infected prosthetic vascular graft excision  Victor Z. Erzurum, MD, Dan Clair,
Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins  Xavier Berard, MD, PhD, Sébastien Déglise, MD, Florian Alonso, PhD,
Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion 
Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb.
Indocyanine green angiography: A new method to quantify collateral flow in mice  Jan C. Wuestenfeld, MD, Joerg Herold, MD, Ulrike Niese, Utz Kappert, MD,
Assessment of mouse hind limb endothelial function by measuring femoral artery blood flow responses  Chao-Hung Wang, MD, Kuo-Ti Chen, MS, Hsiu-Fu Mei,
Seung-Kee Min, MD, PhD, Richard D. Kenagy, PhD, Joseph P
Manuel Caceres, MD, Natalia O. Glebova, MD, PhD 
Tormod S. Westvik, MD, Tamara N
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial.
Dose-dependent neuroprotection of delta-opioid peptide [D-Ala2, D-Leu5] enkephalin on spinal cord ischemia-reperfusion injury by regional perfusion into.
Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis  Masayuki Kubo, PhD, Tao-Sheng Li, MD, PhD, Takahiro.
Feasibility and accuracy of fusion imaging during thoracic endovascular aortic repair  Christof Johannes Schulz, Matthias Schmitt, Dittmar Böckler, MD,
Improved characterization of popliteal aneurysms using gadofosveset-enhanced equilibrium phase magnetic resonance angiography  Mauricio S. Galizia, MD,
Subacute limb ischemia induces skeletal muscle injury in genetically susceptible mice independent of vascular density  Joseph M. McClung, PhD, Timothy.
The role of short-term oxygen administration in the prevention of intimal hyperplasia  Charu Lata, MBBS, Derrick Green, MD, Jing Wan, MD, Sabita Roy, PhD,
Ex vivo gene delivery of ephrin-B2 induces development of functional collateral vessels in a rabbit model of hind limb ischemia  Masatake Katsu, MD, Hiroyuki.
Antisense basic fibroblast growth factor alters the time course of mitogen-activated protein kinase in arterialized vein graft remodeling  Akimasa Yamashita,
A case of intravascular epithelioid hemangioendothelioma occurring 14 years after coil embolization for an extracranial internal carotid artery aneurysm 
Traumatic arteriovenous fistula 52 years after injury
Volume 16, Issue 12, Pages (December 2008)
Autologous skeletal myoblasts transduced with a new adenoviral bicistronic vector for treatment of hind limb ischemia  Muhammad I. Niagara, MSc, Husnain.
Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia  Steven.
Volume 19, Issue 4, Pages (April 2011)
Appropriate control of ex vivo gene therapy delivering basic fibroblast growth factor promotes successful and safe development of collateral vessels in.
Abe DeAnda, MD, Vigneshwar Kasirajan, MD, Daniel Henry, MD, Stuart I
Michel Lacombe, MD  Journal of Vascular Surgery 
Intravascular synovial sarcoma of the external iliac vein and reconstruction with the superficial femoral vein  Jonathan S. White, MD, Shaun A.C. Medlicott,
Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: Roles of endothelial nitric oxide synthase and endothelial.
Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts  Hiroshi Banno, MD, Yoshifumi Takei, PhD,
Remodeling of experimental arteriovenous fistula with increased matrix metalloproteinase expression in rats  Chih-Yang Chan, MD, Yih-Sharng Chen, MD,
Galit Ankri-Eliahoo, PhD, Kevin Weitz, BS, Timothy C. Cox, PhD, Gale L
Presentation transcript:

Thrombin promotes arteriogenesis and hemodynamic recovery in a rabbit hindlimb ischemia model  Konstantinos Katsanos, MD, Dimitrios Karnabatidis, MD, PhD, Athanasios Diamantopoulos, MD, George C. Kagadis, PhD, Panagiota Ravazoula, MD, PhD, George C. Nikiforidis, PhD, Dimitrios Siablis, MD, PhD, Nikos E. Tsopanoglou, PhD  Journal of Vascular Surgery  Volume 49, Issue 4, Pages 1000-1012 (April 2009) DOI: 10.1016/j.jvs.2008.11.004 Copyright © 2009 The Society for Vascular Surgery Terms and Conditions

Fig 1 Flowchart of experimental protocol. Seventy-four (n = 74) New Zealand White rabbits underwent bilateral femoral artery surgical excision. On the 20th postsurgical day increasing doses of thrombin or VEGF or bFGF were injected in one ischemic limb per rabbit and an equal volume of normal saline to the contralateral control limbs; ie, groups of ischemic controls. A group of nonoperated subjects (n = 6) was included in the study as an external control group of normal rabbit hindlimbs; ie, group of normal controls. On the 40th postsurgical day imaging and histology was performed as indicated. Journal of Vascular Surgery 2009 49, 1000-1012DOI: (10.1016/j.jvs.2008.11.004) Copyright © 2009 The Society for Vascular Surgery Terms and Conditions

Fig 2 Thrombin promotes arteriogenesis in the rabbit ischemia model. A, Representative quantitative angiography in normal rabbits. (a) DSA of the rabbit hindlimbs. The normal vascular anatomy of the abdominal aorta (1), the internal iliac artery (2), the femoral artery (3), the profunda femoris (4), and the saphenous artery below the knee (5) are shown. Surgical ischemia is invoked bilaterally by excising the femoral artery (3) and ligating all its branches (vessels within the circles). Hemodynamic functional analysis was performed in the indicated region of tissue (area within the rectangular box). (b) Image analysis and vessel enhancement after sequential filtering and computerized postprocessing. (c) Final image after isolation of the large vessels (d > 500 μm), which permits quantitative measurements of the area and the length of the segmented vessels. (d) Skeletonization of segmented large vessels, which is superimposed on the original DSA image. B, Representative quantitative angiography in thrombin-treated ischemic rabbits. (a) Final DSA angiogram 20 days after intramuscular injection of 5000 IU of thrombin in the right hindlimb of the rabbit. Left (L) foot served as the control foot. (b) Corresponding enhanced image after postprocessing. (c) Segmentation of the large vessels. Red circles include the newly developed collateral vessels. (d) Skeletonization of large vessels to permit calculation of total area and length. C, Quantitation of developed collaterals. Total length and area of large collateral vessels were analyzed in the areas of femoral artery excision 20 days after single intramuscular administration of the indicated doses of VEGF or bFGF or thrombin. Results are expressed as mean percentage change of internal control hindlimbs of each study group ± standard error (SE). Each study group included 7-8 rabbits (*P < .05). Journal of Vascular Surgery 2009 49, 1000-1012DOI: (10.1016/j.jvs.2008.11.004) Copyright © 2009 The Society for Vascular Surgery Terms and Conditions

Fig 3 Effects of 15,000 IU-thrombin administration in rabbit ischemia arteriogenic response. A and B, Total length (A) and area (B) of large collateral vessels were quantified within the regions of interest (the femoral artery excision area) in normal nonoperated rabbits (normal, n = 6) or control ischemic hindlimbs of all treatment groups (control limbs, n = 66) or hindlimbs treated with 5000 IU-thrombin (Thr 5000 IU, n = 7) or hindlimbs treated with 15,000 IU-thrombin (Thr 15,000 IU, n = 8) or contralateral control hindlimbs of the 15,000 IU-thrombin treated limbs (15,000 IU controls, n = 8). Results are expressed as mean pixel counts (each pixel is equal to approximately 200 μm) ± SE. *P < .05, ***P < .001. C, Estimation of collateral diameter (the ratio of vessel area to length) in the regions-of-interest (the femoral artery excision area) in normal nonoperated rabbits (normal, n = 6) or hindlimbs treated with 15,000 IU-thrombin (Thr 15,000 IU, n = 8) or contralateral control hindlimbs of the 15,000 IU-thrombin treated limbs (15,000 IU controls, n = 8). Results are expressed as mean pixel counts ± SE. *P < .05. D, Three-dimensional reconstruction of CT angiogram of bilateral hindlimbs on the 40th postsurgical day (posterior view). White asterisks denote the internal iliac arteries from where helical branching collaterals originate (double white arrow). Saphenous arteries reconstitute through collateral blood flow at the level of the knee (dotted white lines). Journal of Vascular Surgery 2009 49, 1000-1012DOI: (10.1016/j.jvs.2008.11.004) Copyright © 2009 The Society for Vascular Surgery Terms and Conditions

Fig 4 Histopathologic analysis. A, Immunolocalization of arterioles. Anti-CD31 staining of histologic sections of ischemic hindlimbs adductor muscle tissue 20 days after treatment with saline (control ischemic hindlimbs) or the indicated doses of VEGF or bFGF or thrombin (Thr). Representative photos are shown (Original magnification ×20; black arrows point to arterioles). B, Count of arterioles per optical field. Stained vessels were counted in the histologic sections of control ischemic hindlimbs (control limbs) or of hindlimbs treated with indicated doses of VEGF, bFGF, and thrombin (Thr) or the contralateral control hindlimbs of the 15,000 IU-thrombin treated limbs (15,000 IU controls). Results are expressed as mean arteriolar count ± SE. *P < .05. C, Hematoxylin-eosin (left image) and positive PGM1 immunostaining (right image) of adductor muscle specimens treated with 15,000 IU thrombin. Note the abundant proliferation and infiltration of nonspecific cells (magnification ×40). Immunoreactions of these cells were positive for PGM1 and PK1 (fibroblast-specific immunomarkers) and also positive for Sm-Actin, Vimentin, and S100 (relating to differentiating monocyte cells of mesenchymal origin, data not shown). Journal of Vascular Surgery 2009 49, 1000-1012DOI: (10.1016/j.jvs.2008.11.004) Copyright © 2009 The Society for Vascular Surgery Terms and Conditions

Fig 5 Cross-sectional CT and MR of 15,000 IU-thrombin treated rabbits. A, Representative axial (left panel) and parasagittal (right panel) maximum intensity projection (MIP) contrast-enhanced CT images of rabbit limbs 20 days after single intramuscular injection of 15,000 IU of thrombin. B, Representative axial MR images pre- (left panel) and postgadolinium injection (right panel) of rabbits 20 days after single intramuscular administration with 15,000 IU of thrombin. Note the higher enhancement and signal intensity of the muscle injected with 15,000 IU thrombin (white arrows). Journal of Vascular Surgery 2009 49, 1000-1012DOI: (10.1016/j.jvs.2008.11.004) Copyright © 2009 The Society for Vascular Surgery Terms and Conditions

Fig 6 Thrombin improves hemodynamic recovery in the rabbit ischemia model. A, Representative dynamic computed tomography of rabbit saphenous arteries 20 days after administration of 5000 IU-thrombin (right limb). Top baseline cross-sectional image at a distal level below-the-knee before infusion of iodinated contrast from a marginal auricular vein. A region-of-interest was set within the intravascular space of the saphenous artery (bright vessels within the red and yellow circles). Intermediate image after contrast infusion and arrival of contrast shows peak enhancement of the arteries. The bright enhancement within the arteries corresponds to the circulating blood volume. Bottom final image after digital subtraction of the above. B, Perfusion analysis of dynamic-CT study. Peak vessel enhancement (left panel) and the corresponding time-to-peak intervals (right panel) were calculated in the regions of saphenous arteries 20 days after single intramuscular administration of the indicated doses of VEGF or bFGF or thrombin. Results expressed as mean percentage change in comparison to internal control hindlimbs of each study group ± SE. Each study group included seven to eight rabbits. *P < .05. C, Average time-resolved curves of saphenous artery enhancement were calculated in normal nonoperated hindlimbs (normal, n = 6) or total control ischemic hindlimbs (control limbs, n = 66) or hindlimbs treated with indicated doses of thrombin (n = 7) or VEGF (n = 8) or bFGF (n = 8) or contralateral control hindlimbs of the 15,000 IU-thrombin treated limbs (15,000 IU controls, n = 8). Results expressed as mean Hounsfield Units ± SE. D and E, Dynamic CT perfusion analysis of 15,000 IU-thrombin treated rabbits. Peak vessel enhancement (D) and the corresponding time-to-peak enhancement (E) were calculated in the regions of saphenous arteries 20 days after single intramuscular administration of 15,000 IU thrombin. Results expressed as mean Hounsfield Units ± SE (left panel) or as mean seconds ± SE (right panel). ***P < .001. F, Semiquantitative perfusion score calculated with the slope method.24 *P < .05. Journal of Vascular Surgery 2009 49, 1000-1012DOI: (10.1016/j.jvs.2008.11.004) Copyright © 2009 The Society for Vascular Surgery Terms and Conditions